Literature DB >> 9157162

Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.

D Sullivan1, K Haynes, J Bille, P Boerlin, L Rodero, S Lloyd, M Henman, D Coleman.   

Abstract

Candida dubliniensis is a recently identified chlamydospore-positive yeast species associated with oral candidiasis in human immunodeficiency virus (HIV)-infected (HIV+) patients and is closely related to Candida albicans. Several recent reports have described atypical oral Candida isolates with phenotypic and genetic properties similar to those of C. dubliniensis. In this study 10 atypical chlamydospore-positive oral isolates from HIV+ patients in Switzerland, the United Kingdom, and Argentina and 1 isolate from an HIV-negative Irish subject were compared to reference strains of C. albicans and Candida stellatoidea and reference strains of C. dubliniensis recovered from Irish and Australian HIV+ individuals. All 11 isolates were phenotypically and genetically similar to and phylogenetically identical to C. dubliniensis. These findings demonstrate that the geographical distribution of C. dubliniensis is widespread, and it is likely that it is a significant constituent of the normal oral flora with the potential to cause oral candidiasis, particularly in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157162      PMCID: PMC229710          DOI: 10.1128/jcm.35.4.960-964.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting.

Authors:  J Schmid; F C Odds; M J Wiselka; K G Nicholson; D R Soll
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

Authors:  P Boerlin; F Boerlin-Petzold; C Durussel; M Addo; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.

Authors:  M McCullough; B Ross; P Reade
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

5.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

Review 6.  Oral Candida in HIV infection and AIDS: new perspectives/new approaches.

Authors:  D C Coleman; D E Bennett; D J Sullivan; P J Gallagher; M C Henman; D B Shanley; R J Russell
Journal:  Crit Rev Microbiol       Date:  1993       Impact factor: 7.624

7.  Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.

Authors:  P J Gallagher; D E Bennett; M C Henman; R J Russell; S R Flint; D B Shanley; D C Coleman
Journal:  J Gen Microbiol       Date:  1992-09

8.  A Candida albicans dispersed, repeated gene family and its epidemiologic applications.

Authors:  S Scherer; D A Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

Review 10.  Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species.

Authors:  D J Sullivan; M C Henman; G P Moran; L C O'Neill; D E Bennett; D B Shanley; D C Coleman
Journal:  J Med Microbiol       Date:  1996-06       Impact factor: 2.472

View more
  57 in total

1.  First report of Candida dubliniensis in the Middle East.

Authors:  D A Stevens
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  One-year prevalence of Candida dublinienis in a Dutch university hospital.

Authors:  J F Meis; F M Lunel; P E Verweij; A Voss
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions.

Authors:  W R Kirkpatrick; J L Lopez-Ribot; R K McAtee; T F Patterson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens.

Authors:  Claudia Schabereiter-Gurtner; Brigitte Selitsch; Manfred L Rotter; Alexander M Hirschl; Birgit Willinger
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 6.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.

Authors:  M A Pfaller; S A Messer; S Gee; S Joly; C Pujol; D J Sullivan; D C Coleman; D R Soll
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Racial distribution of Candida dubliniensis colonization among South Africans.

Authors:  Elaine Blignaut; Claude Pujol; Sophie Joly; David R Soll
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.

Authors:  J Bikandi; R S Millán; M D Moragues; G Cebas; M Clarke; D C Coleman; D J Sullivan; G Quindós; J Pontón
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.